• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Opinions
    • Top 30
    • Research
    • Supply Chain
    • Device Sectors
    • Directory
    • Events
    • Resources
    • Microsites
    • More
  • Magazine
  • News
  • Opinions
  • Top 30
  • Research
  • Supply Chain
  • Device Sectors
  • Directory
  • Events
  • Resources
  • Microsites
  • Current / Back Issues
    Features
    Editorial
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Reprints
    Subscribe Now
    Advertise Now
    Top Features
    Computer Concepts for Medical Device Design

    IVD Manufacturers Are Being Put to the Test

    The New State of Medtech Outsourcing

    The Changing Face of Medtech Surface Treatment

    The Totally Tubular Technologies that Support Medical Devices
    OEM News
    Supplier News
    Service / Press Releases
    Online Exclusives
    Press Releases
    People in the News
    Product & Service Releases
    Supplier News
    Medtech Makers
    Technical Features
    International News
    Videos
    Product & Service Releases
    Live From Shows
    Regulatory
    Financial/Business
    Top News
    Vascular Surgeon Imprisoned and Fined for Decade-Long Healthcare Fraud

    Remote Monitoring, Digital Health Help Advance Wound Care Treatment

    MLM Biologics Developing Wound Infection Prevention Device for Military

    NovaScan, PHC Corporation Working on Skin Cancer Detection Device

    Ur24Technology Granted Medicare Reimbursement for External Catheter System
    From the Editor
    Blogs
    Guest Opinions
    Top Opinions
    Computer Concepts for Medical Device Design

    IVD Manufacturers Are Being Put to the Test

    The New State of Medtech Outsourcing

    The Changing Face of Medtech Surface Treatment

    The Totally Tubular Technologies that Support Medical Devices
    Top 30 Medical Device Companies
    Market Data
    White Papers
    Top Research
    Checking Up on Surgical Robotics

    Building a Network: How Synchron Is Developing a New Device—and a New Market

    Six Lessons Learned on Developing a Strong Company Culture

    As Hiring Slows, Companies Look Inward to Fulfill Talent Needs

    Artificial Intelligence: Medtech Opportunity or Health Danger?
    3D/Additive Manufacturing
    Contract Manufacturing
    Electronics
    Machining & Laser Processing
    Materials
    Molding
    Packaging & Sterilization
    R&D & Design
    Software & IT
    Testing
    Tubing & Extrusion
    Cardiovascular
    Diagnostics
    Digital Health
    Neurological
    Patient Monitoring
    Surgical
    Orthopedics
    All Companies
    Categories
    Company Capabilities
    Add New Company
    Outsourcing Directory
    JBC Technologies

    LEMO USA Inc.

    Providence Enterprise USA Inc.

    Arthur G. Russell Co. Inc., The

    Medbio LLC
    MPO Summit
    Industry Events
    Webinars
    Live From Show Event
    Industry Associations
    Videos
    Career Central
    eBook
    Slideshows
    Top Resources
    3 Key Elements to Consider When Managing a Medtech Sales Force

    Tech-Enabled Virtual Speech Therapy Improves Speech & Communication Skills

    Practical Strategies for Digitization and Integration in Medtech Manufacturing

    Sensors: The Heart of Minimally Invasive Equipment Technology

    Optimizing UX for the Internet of Medical Things
    Companies
    News Releases
    Product Releases
    Press Releases
    Product Spec Sheets
    Service Releases
    Case Studies
    White Papers
    Brochures
    Videos
    Outsourcing Directory
    JBC Technologies

    LEMO USA Inc.

    Providence Enterprise USA Inc.

    Arthur G. Russell Co. Inc., The

    Medbio LLC
    • Magazine
      • Current/Back Issues
      • Features
      • Editorial
      • Columns
      • Digital Editions
      • Subscribe Now
      • Advertise Now
    • News
    • Directory
      • All Companies
      • ALL CATEGORIES
      • Industry Associations
      • Company Capabilities
      • Add Your Company
    • Supply Chain
      • 3D/Additive Manufacturing
      • Contract Manufacturing
      • Electronics
      • Machining & Laser Processing
      • Materials
      • Molding
      • Packaging & Sterilization
      • R&D & Design
      • Software & IT
      • Testing
      • Tubing & Extrusion
    • Device Sectors
      • Cardiovascular
      • Diagnostics
      • Digital Health
      • Neurological
      • Patient Monitoring
      • Surgical
      • Orthopedics
    • Top 30 Company Report
    • Expert Insights
    • Slideshows
    • Videos
    • eBook
    • Resources
    • Podcasts
    • Infographics
    • Whitepapers
    • Research
      • White Papers
      • Case Studies
      • Product Spec Sheets
      • Market Data
    • MPO Summit
    • Events
      • Industry Events
      • Live From Show Events
      • Webinars
    • Microsite
      • Companies
      • Product Releases
      • Product Spec Sheets
      • Services
      • White Papers / Tech Papers
      • Press Releases
      • Videos
      • Literature / Brochures
      • Case Studies
    • About Us
      • About Us
      • Contact Us
      • Advertise with Us
      • eNewsletter Archive
      • Privacy Policy
      • Terms of Use
    Columns

    A Breakthrough for the Nightmarish Effects of PTSD

    ...

    A Breakthrough for the Nightmarish Effects of PTSD
    Sam Brusco, Associate Editor06.13.19
    Though I am not a particularly strong supporter of Apple—and you’re welcome to contact me to find out why—I have to admit the Apple Watch could be a useful tool for proactive health monitoring.

    The Apple Watch Series 4, released last year, came equipped with an electrocardiogram (ECG) sensor and app to capture the heart’s rhythm. The company did its homework and also obtained clearance from the U.S. Food and Drug Administration (FDA) for the ECG tool around the time of release. Health Canada also issued active licenses for the ECG and irregular heart rhythm notification features on May 16.

    Further affirming the feature’s utility, Stanford University School of Medicine shared the early results of a 400,000-participant study during the last week of April to determine if the mobile app could accurately identify atrial fibrillation (AFib). Stanford researchers reported the wearable technology can safely identify heart rate irregularities, which subsequent testing confirmed to be AFib.

    This clearance has opened the door for other health-conscious smartwatch applications running on the Apple Watch Platform. They don’t necessarily have to be directly cardiac related, either. For example, on May 21, NightWare Inc., a Minneapolis-based startup that develops digital therapeutics for mental health, received FDA Breakthrough Status for its NightWare product, which measures and treats nightmares for sufferers of post-traumatic stress disorder (PTSD).

    Among the many other disconcerting symptoms of PTSD, it is estimated that almost 5 million Americans suffer from Nightmare Disorder related to PTSD. Nightmares and Nightmare Disorder have long been associated with a slew of worrisome effects—increased suicidality, heightened heart disease risk and diabetes, and cognitive difficulties like memory loss, anxiety, and depression. A single nightmare event is enough to make anyone anxious or upset, but repeated nightmares and interrupted sleep can bring PTSD sufferers’ trauma to the forefront nearly every night.

    For those unfamiliar with what a Breakthrough Designation means, it occurs when the FDA recognizes a therapeutic solution for a life-threatening condition for which no currently approved treatment is able to offer similar benefits to the proposed therapy. This designation allows the FDA to grant priority review when preliminary clinical trials indicate a given therapy might offer substantial advantages over existing options for patients with serious or life-threatening diseases. A breakthrough therapy designation is requested by the company providing the solution. In some cases, the FDA may suggest the sponsor consider submitting a breakthrough request if, after reviewing the submitted data, the agency thinks the program might meet breakthrough criteria and the development program will benefit from the designation.

    “This is truly a watershed moment for our company,” NightWare CEO and founder Grady Hannah told the press. “In our initial studies, NightWare has demonstrated substantial and significant efficacy. The FDA’s Breakthrough Status designation will enable us to complete our Randomized Clinical Trials ahead of schedule and give us the opportunity to help improve the lives of veterans and others suffering from PTSD sooner than we anticipated. Our team is humbled and excited by this FDA designation.”

    The NightWare application operates by tracking, intervening, and processing nightmare events. As the wearer slumbers, the app continuously analyzes heart rate, accelerometer, and gyroscope data collected from the Apple Watch’s integrated sensors to learn sleep patterns in the first few days of wearing the watch each night. The “learning period” usually takes less than 10 days to apply machine learning algorithms for a profile of the individual’s sleep patterns. A “stress threshold” is computed during this time based on spikes in heart rate and movement, indicating a nightmare event has begun.

    Once the learning period is over, whenever the application detects a potential nightmare it intervenes by vibrating (also called vibrotactile feedback). The watch will vibrate enough to arouse the sleeper out of sleep without waking them. The intended result is the nightmare is interrupted by the sudden arousal without interrupting the sleeper’s circadian sleep pattern, allowing for high quality, more restful sleep.

    The app begins with low-intensity vibration. But if it detects the nightmare event has not been halted, the app increases the intervention intensity. The watch app also sends the collected data to a secure cloud service to facilitate review by a healthcare professional. NightWare also comes equipped with a desktop app to display stress, intervention, and other collected data. Tech-savvy individuals can use the desktop app to review their data, or a healthcare professional could use it to review data for multiple users.

    “We’ve seen a markedly large effect size for improved sleep quality in NightWare open label trials,” NightWare Chief Medical Officer Daniel Karlin, M.D. commented to the press. “We are excited to get folks enrolled in these randomized trials to further verify the observed efficacy.”

    NightWare is early in development and currently not available for sale. The company is currently enrolling patients in two randomized clinical trials (RCT), one of which is being conducted at VA hospitals in Minneapolis and St. Cloud, Minn. The company is also enrolling in a virtual RCT trial broader in geographic scope. If interested, prospective participants can get more information about enrollment at http://bit.ly/2W1it51. 
    Related Searches
    • company
    • heart disease
    • testing
    • wearable
    Related Knowledge Center
    • Digital Health
    • Neurological
    Suggested For You
    BRAINBox BRAINBox's Traumatic Brain Injury Test Wins Breakthrough Status
    6 Trends Reshaping Medical Equipment Manufacturing 6 Trends Reshaping Medical Equipment Manufacturing
    FDA Authorizes First Test to Detect Zika Antibodies FDA Authorizes First Test to Detect Zika Antibodies
    FDA Offers Update on Efforts to Ensure Breast Implant Safety FDA Offers Update on Efforts to Ensure Breast Implant Safety
    FDA Approves Device to Help Increase Access to More Lungs for Transplant FDA Approves Device to Help Increase Access to More Lungs for Transplant
    Apple Heart Study Demonstrates Ability of Wearable Technology to Detect Atrial Fibrillation Apple Heart Study Demonstrates Ability of Wearable Technology to Detect Atrial Fibrillation
    Orchestra BioMed Orchestra BioMed's Virtue Sirolimus-Eluting Balloon Wins Breakthrough Status
    FDA Takes Steps to Reduce Surgical Stapler Risks FDA Takes Steps to Reduce Surgical Stapler Risks
    FDA Halts Sale of Pelvic Mesh in U.S. FDA Halts Sale of Pelvic Mesh in U.S.
    FDA Warns Genomics Lab About Illegally Marketing Genetic Test FDA Warns Genomics Lab About Illegally Marketing Genetic Test
    A New, Tailored Review Framework for Artificial Intelligence-Based Devices A New, Tailored Review Framework for Artificial Intelligence-Based Devices
    Cardiac Care on the Can Cardiac Care on the Can
    Study: Apple Watch May Help Flag Heart Rhythm Problems Study: Apple Watch May Help Flag Heart Rhythm Problems
    It’s Time to Embrace Customer Centricity It’s Time to Embrace Customer Centricity
    Sum and Substance: Material Considerations for Changing Design Needs Sum and Substance: Material Considerations for Changing Design Needs

    Related Breaking News

    • Diagnostics | Neurological
      BRAINBox

      BRAINBox's Traumatic Brain Injury Test Wins Breakthrough Status

      BRAINBox TBI is a first-of-its-kind device to aid in concussion diagnosis and prognosis.
      PR Newswire 06.06.19

    • Contract Manufacturing | Digital Health | Software & IT | Surgical
      6 Trends Reshaping Medical Equipment Manufacturing

      6 Trends Reshaping Medical Equipment Manufacturing

      Medical device manufacturers and end users alike must keep an eye on current industry trends in order to prepare and adapt.
      Megan Ray Nichols, Science Writer; Editor, Schooled By Science 05.30.19

    • Diagnostics
      FDA Authorizes First Test to Detect Zika Antibodies

      FDA Authorizes First Test to Detect Zika Antibodies

      The ZIKV Detect 2.0 IgM Capture ELISA is the first Zika diagnostic test the FDA has allowed to be marketed in the U.S.
      U.S. Food and Drug Administration 05.24.19


    • Surgical
      FDA Offers Update on Efforts to Ensure Breast Implant Safety

      FDA Offers Update on Efforts to Ensure Breast Implant Safety

      FDA hopes to ensure that women have the most complete information available to make important breast implant decisions.
      Amy Abernethy, M.D., Ph.D., FDA Principal Deputy Commissioner; Jeff Shuren, M.D., J.D., CDRH Director 05.06.19

    • Surgical
      FDA Approves Device to Help Increase Access to More Lungs for Transplant

      FDA Approves Device to Help Increase Access to More Lungs for Transplant

      The Xvivo Perfusion System allows the transplant team to perform a more careful assessment of lung function.
      PR Newswire 04.30.19

    Loading, Please Wait..

    Trending
    • Vascular Surgeon Imprisoned And Fined For Decade-Long Healthcare Fraud
    • Philips Names New Supervisory Board Chairman
    • A New Approach To Post-Market Surveillance
    • Healthcare Changes Prompt Medtronic To Merge Sales Force Medtronic, Inc. Is Combining Its U.S. Ca
    • FDA Clears LiveMetric's Wearable Blood Pressure Monitoring Tech
    Breaking News
    • Vascular Surgeon Imprisoned and Fined for Decade-Long Healthcare Fraud
    • Remote Monitoring, Digital Health Help Advance Wound Care Treatment
    • MLM Biologics Developing Wound Infection Prevention Device for Military
    • NovaScan, PHC Corporation Working on Skin Cancer Detection Device
    • Ur24Technology Granted Medicare Reimbursement for External Catheter System
    View Breaking News >
    CURRENT ISSUE

    May 2023

    • Computer Concepts for Medical Device Design
    • IVD Manufacturers Are Being Put to the Test
    • The New State of Medtech Outsourcing
    • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    Premium Label & Packaging Solutions Receives Safe Quality Food (SQF) Certification
    Inulinase Enzymes May Benefit Gut Symptoms of FODMAP Digestion
    Verdure Sciences’ Boswellia Ingredient Receives USP Verification
    Coatings World

    Latest Breaking News From Coatings World

    OQ Chemicals Launches Cost-Cutting Program and Organizational Realignment in Germany
    BASF Strengthens R&D with More Powerful Supercomputer
    Safic-Alcan Expands its Presence in Africa with the Launch of Safic-Alcan East Africa in Kenya
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    Vascular Surgeon Imprisoned and Fined for Decade-Long Healthcare Fraud
    Remote Monitoring, Digital Health Help Advance Wound Care Treatment
    MLM Biologics Developing Wound Infection Prevention Device for Military
    Contract Pharma

    Latest Breaking News From Contract Pharma

    Catalent Adds New Cryogenic Capabilities at Japanese Facility
    Lifecore Biomedical Enters into $150M New Financing Deal
    WuXi Biologics Receives 2023 ISPE Facility of the Year Award
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    How Robots & Artificial Intelligence are Transforming Unilever's Material Innovation Factory
    Top 10 Most Popular Hair Care Brands in the U.S.—Ranked by Searches
    Aloette Cosmetics Launches Daily Mineral Shield Sunscreen
    Happi

    Latest Breaking News From Happi

    Revieve Launches Beauty Technology Platform on Google Cloud Marketplace
    BBW’s Fabric Softener Launch, Ameon’s New Ambassador
    Mielle Organics Taps Angel Reese as New Ambassador
    Ink World

    Latest Breaking News From Ink World

    Weekly Recap: INX Digital, Mexar and hubergroup Top This Week’s Stories
    Richnerstutz AG Acquires an EFI VUTEk Q5r Superwide Roll-to-Roll Printer
    BASF Strengthens Its R&D with More Powerful Supercomputer
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    Mactac acquires Label Supply, Beontag grows and more
    Sun Chemical releases Spring 2023 Regulatory Newsletter
    Tageos unveils new RAIN RFID inlays
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    Weekly Recap: Corman, Tosama Develop Biodegradable Plastic Tampon Applicator, Trevira Changes Name
    Suominen Appoints SVP, Transformation Management Office
    Minnesota Signs PFAS Ban in Consumer Products
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    AlloSource Launches AlloMend Duo Acellular Dermal Matrix
    TendoNova Inks Partnership With AcCELLerated Biologics
    Stryker Achieves First Surgeries Using Q Guidance System with Cranial Guidance Software
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    Weekly Recap: Smart Skis, Universal Display Top This Week’s Stories
    Wiliot Appoints Antony Yousefian as VP of Climate & Circularity
    HID Unveils Eco-friendly Bamboo Access Cards

    Copyright © 2023 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login